Lack of evidence of measles virus shedding in people with inapparent measles virus infections

Journal of Infectious Diseases

Volumn 189, Issue SUPPL. 1, 2004, Pages

  Lievano, Fabio A ^a,c   Papania, Mark J ^a   Helfand, Rita F ^b   Harpaz, Rafael ^a   Walls, Laura ^b   Katz, Russell S ^b   Williams, Irene ^b   Villamarzo, Yvonne S ^b   Rota, Paul A ^b   Bellini, William J ^b  

^a Child Vacc Preventable Dis Branch   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HUMAN; LYMPHOCYTE; MALE; MEASLES; MEASLES VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SERUM; THROAT CULTURE; URINALYSIS; VIRUS INFECTION; VIRUS ISOLATION; VIRUS SHEDDING;

EID: 2442429595     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377715     Document Type: Article

References (28)

1. Edmoston MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990; 263:2467-71.
2. Huiss S, Damien B, Schneider F, Muller CP. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors. Clin Exp Immunol 1997; 109:416-20.
3. Muller CP, Huiss S, Schneider F. Secondary immune responses in parents of children with recent measles. Lancet 1996; 348:1379-80.
4. Ozanne G, D'Halewyn MA. Secondary immune response in a vaccinated population during a large measles epidemic. J Clin Microbiol 1992; 30:1778-82.
5. Helfand RF, Kim DK, Gary HE, et al. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol 1998; 56:337-41.
6. Vardas E, Kreis S. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. J Clin Virol 1999; 13:173-9.
7. Pedersen IR, Mordhorst CH, Glikmann G, von Magnus H. Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Vaccine 1989; 7:345-8.
8. Chen RT, Markowitz LE, Albretch P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990; 162:1036-42.
9. Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999; 353:98-102.
10. Reyes MA, De Borrero MF, Roa J, Bergonzoli G, Saravia NG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987;6:848-51.
11. Centers for Disease Control and Prevention. Measles. Pink book. 5th ed. Atlanta: Centers for Disease Control and Prevention, 1999:135-59.
12. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3d ed. Philadelphia: WB Saunders, 1999: 222-66.
13. Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of inapparent measles transmission in vaccinated populations with waning immunity. Am J Epidemiol 1999; 150: 1238-49.
14. Centers for Disease Control and Prevention. Transmission of measles among a highly vaccinated school population - Anchorage, Alaska 1998. MMWR Morb Mortal Wkly Rep 1999; 47:1109-11.
15. Erdman DD, Anderson LJ, Adams DR, Stewart JA, Markowitz LE, Bellini WJ. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol 1991; 29:1466-71.
16. Ratnam S, Tipples G, Head C, Fauvel M, Fearon M, Ward BJ. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol 2000; 38:99-104.
17. Hummel KB, Erdman DD, Heath J, Bellini WJ. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol 1992; 30:2874-80.
18. Albrecht P, Hermann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3:251-60.
19. Kobune F, Sakata H, Sugira A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 1990; 64:700-5.
20. Rota PA, Khan AS, Durigon E, Yuran T, Villamarzo YS, Bellini WJ. Detection of measles virus RNA in urine specimens from vaccine recipients. J din Microbiol 1995; 33:2485-88.
21. Lynn TV, Beller M, Funk EA, et al. The incremental effectiveness of 2 doses of measles-containing vaccine compared with 1 among high school students during an outbreak. J Infect Dis 2004; 189(Suppl 1): S86-90.
22. Rota PA, Liffick SL, Rota JS, et al. Molecular epidemiology of measles viruses in the United States: 1997-2001. Emerg Infect Dis 2002; 8: 902-8.
23. Centers for Disease Control and Prevention. Measles - United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47:273-6.
24. Centers for Disease Control and Prevention. Epidemiology of measles - United States, 1998. MMWR Morb Mortal Wkly Rep 1999; 48: 749-53.
25. Centers for Disease Control and Prevention. Measles - United States, 1999. MMWR Morb Mortal Wkly Rep 2000; 49:557-60.
26. Moss WJ, Cults F, Griffin D. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis 1999; 29:106-12.
27. Cutts FT, Henao-Restrepo AM, Olive JM. Measles elimination: progress and challenges. Vaccine 1999; 17:S47-52.
28. Biellik R, Madema S, Taole A, et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002; 359:1564-8.